Compare Guardant Health Inc. Common Stock (GH) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Guardant Health Inc. Common Stock trades at $167.47 (market cap $22.22B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $61.09 (market cap $44.49B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 2× Guardant Health Inc. Common Stock's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and JPMorgan Nasdaq Equity Premium Income ETF for 66 Days on average.
| GH | JEPQ | |
|---|---|---|
Market Cap | $22.22B | $44.49B |
Volume | 1,589,453 | 5,681,789 |
Sector | Health | Income / Options Overlay |
52-Week High | $187.22 | $61.46 |
52-Week Low | $61.73 | $53.77 |
Typical Hold Time | 1 Days | 66 Days |
Enterprise Value | $22.86B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JEPQ trades at $60.93, down 0.55% today, with a bullish technical signal from moving averages while oscillators remain neutral. The ETF maintains strong income generation through its covered-call strategy on Nasdaq-100 stocks, with recent dividends ranging from $0.57 to $0.70 per share. Current price action shows support at $60-$61 levels with resistance near $62.
The outlook remains positive for income-focused investors seeking Nasdaq exposure with downside protection, though limited price appreciation potential and variable dividend payments present key considerations. Market volatility drives income generation, making JEPQ suitable for retirees seeking monthly cash flow but less ideal for growth-oriented portfolios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
